Honliv Healthcare Management Group Co Ltd (HK:9906)
:9906
Top Page
Honliv Healthcare Management Group Co Ltd
(9906)
Select Model
Select Model
Rating:51Neutral
Price Target:
HK$1.50
▼(-14.29% Downside)
Action:N/ADate:07/19/25
Honliv Healthcare's overall score of 51 is primarily driven by mixed financial performance, with a stable balance sheet and improved cash flows offset by declining profitability margins. Technical indicators suggest caution due to overbought conditions and a longer-term downtrend, while valuation remains neutral with a reasonable P/E ratio but no dividend yield.
Positive Factors
Financial Stability
A strong equity position and low debt-to-equity ratio indicate financial stability, providing a solid foundation for future growth and resilience against economic fluctuations.
Negative Factors
Profit Margin Pressure
Declining gross profit margins indicate rising cost pressures, which could challenge the company's ability to maintain profitability unless addressed through cost control or pricing strategies.
Read all positive and negative factors
Positive Factors
Negative Factors
Financial Stability
A strong equity position and low debt-to-equity ratio indicate financial stability, providing a solid foundation for future growth and resilience against economic fluctuations.
Read all positive factors
Honliv Healthcare Management Group Co Ltd (9906) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$936.00M
Dividend YieldN/A
Average Volume (3M)600.00
Price to Earnings (P/E)―
Beta (1Y)0.15
Revenue Growth-13.22%
EPS Growth-69.35%
CountryHK
Employees1,955
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)N/A
Shares Outstanding600,000,000
10 Day Avg. Volume800
30 Day Avg. Volume600
Financial Highlights & Ratios
PEG Ratio-2.54
Price to Book (P/B)1.87
Price to Sales (P/S)1.40
P/FCF Ratio34.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Honliv Healthcare Management Group Co Ltd Business Overview & Revenue Model
Company Description
Honliv Healthcare Management Group Company Limited owns and operates a general hospital in Mainland China. The company provides medical and pharmaceutical services, and hospital management services. It also operates as the pharmaceutical wholesale...
How the Company Makes Money
Honliv Healthcare Management Group Co Ltd generates revenue through multiple streams. Primarily, the company earns money by providing management services to hospitals and healthcare facilities, which includes operational oversight, strategic plann...
Honliv Healthcare Management Group Co Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
70
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 700.37M | 768.73M | 760.53M | 727.79M | 606.84M | 524.04M |
| Gross Profit | 100.87M | 126.69M | 144.84M | 138.40M | 135.31M | 137.59M |
| EBITDA | 91.33M | 125.80M | 119.31M | 127.13M | 98.20M | 79.43M |
| Net Income | 10.44M | 31.15M | 38.31M | 48.95M | 36.62M | 21.84M |
Balance Sheet | ||||||
| Total Assets | 894.73M | 974.00M | 968.71M | 935.04M | 961.71M | 972.46M |
| Cash, Cash Equivalents and Short-Term Investments | 286.78M | 258.50M | 239.75M | 255.24M | 263.61M | 302.48M |
| Total Debt | 136.08M | 176.04M | 180.76M | 143.12M | 188.48M | 250.05M |
| Total Liabilities | 333.92M | 395.08M | 421.26M | 380.37M | 395.08M | 442.85M |
| Stockholders Equity | 554.90M | 573.00M | 541.85M | 549.47M | 561.83M | 525.21M |
Cash Flow | ||||||
| Free Cash Flow | 78.49M | 31.19M | 2.01M | 98.66M | 40.08M | -6.24M |
| Operating Cash Flow | 106.66M | 83.34M | 91.56M | 118.47M | 91.44M | 74.61M |
| Investing Cash Flow | -19.39M | -51.38M | -88.76M | -19.16M | -50.46M | -80.06M |
| Financing Cash Flow | -60.68M | -13.30M | -19.12M | -117.85M | -76.87M | 215.16M |
Honliv Healthcare Management Group Co Ltd Technical Analysis
Negative
1.75
Price Trends
1.61
Negative
1.65
Negative
1.59
Negative
Market Momentum
-0.01
Negative
1.32
Positive
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9906, the sentiment is Negative. The current price of 1.75 is above the 20-day moving average (MA) of 1.56, above the 50-day MA of 1.61, and above the 200-day MA of 1.59, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 1.32 is Positive, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:9906.
Honliv Healthcare Management Group Co Ltd Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$678.82M | 3.30 | 5.29% | 9.14% | 0.47% | 50.46% | |
66 Neutral | HK$1.32B | 5.35 | 20.47% | 4.37% | -3.56% | -17.45% | |
56 Neutral | HK$545.87M | 5.00 | 31.63% | ― | 2.30% | ― | |
52 Neutral | HK$311.23M | 4.11 | 3.54% | 3.75% | 9.07% | 8.95% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | -275.87 | 1.85% | ― | -13.22% | -69.35% | |
48 Neutral | HK$1.03B | 39.67 | 1.30% | ― | -4.30% | 13.83% |
* Healthcare Sector Average
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.02
1.30%
HK:1419
Human Health Holdings Ltd.
0.82
0.07
9.33%
HK:1526
Rici Healthcare Holdings Ltd.
0.83
-0.34
-29.06%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.20
10.93%
HK:3869
Hospital Corporation of China Ltd
3.95
-2.85
-41.91%
HK:6639
Arrail Group Ltd.
1.83
-0.15
-7.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.